By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Novartis AG 

Lichtstrasse 35

Basel    CH-4056  Switzerland
Phone: 41-0-61-3241111 Fax: 41-0-61-3248001


Novartis is located in East Hanover, New Jersey, Novartis Pharmaceuticals Corporation is an affiliate of Novartis AG, which provides innovative healthcare solutions that address the evolving needs of patients and societies. Headquartered in Basel, Switzerland, Novartis offers a diversified portfolio to best meet these needs: innovative medicines, eye care and cost-saving generic pharmaceuticals. Novartis is the only global company with leading positions in these areas. In 2015, the Group achieved net sales of USD 49.4 billion, while R&D throughout the Group amounted to approximately USD 8.9 billion (USD 8.7 billion excluding impairment and amortization charges). Novartis Group companies employ approximately 118,000 full-time-equivalent associates. Novartis products are available in more than 180 countries around the world.

For more information, visit and follow us on




CEO: Joseph Jimenez

CMO: Vasant (Vas) Narasimhan

CFO: Harry Kirsch


Please click here for Novartis job opportunities.


Please click here for clinical trial information.


All Products


Key Statistics

Ownership: Subsidiary

Web Site: Novartis AG
Symbol: NVS


Company News
Novartis AG (NVS) CEO Thinks The Drug Pricing Debate Will Get "More Difficult" In The Next 3-5 Years 10/26/2016 7:14:54 AM
Turning Around Novartis AG (NVS)'s Struggling Alcon (ACL) Unit Will Take Longer Than Expected 10/26/2016 7:06:05 AM
This is Why Novartis AG (NVS) Folded Its CAR-T Unit 10/26/2016 6:31:40 AM
Novartis AG (NVS) Has Up to $5 Billion Burning in Its Pocket for M&As 10/26/2016 6:29:39 AM
Merck & Co. (MRK) and Novartis AG (NVS) CEOs Blueprint What's on Their M&A Wish List for 2017 10/26/2016 6:25:39 AM
Watch Out Juno (JUNO) and Kite Pharma (KITE): Novartis AG (NVS) Clearly Not Done With CAR-T 10/25/2016 6:12:56 AM
Novartis AG (NVS) May Be Too Generic 10/24/2016 7:40:29 AM
Struggling Cerulean (CERU) Inks Deal Worth $1.2 Billion With Pharma Giant Novartis AG (NVS) 10/20/2016 7:31:43 AM
Novartis AG (NVS) Taps Facebook Live Event To Promote Heart Failure Drugs 10/20/2016 7:18:52 AM
Former Novartis AG (NVS) CAR-T Scientist Jumps to TxCell to Lead CAR-Treg Research Programs 10/14/2016 9:38:29 AM